David Z. Drew, MD

David Z. Drew, MD
Accepting New PatientsAccepting New Patients

David Z. Drew, MD

Star with circle Star with circle Star with circle Star with circle Star with circle 4.7/5.0
See Reviews
  • Specialities: Hematology and Oncology
  • Office Hours:Monday-Friday 9:00 am to 12:00 pm, 1:00 pm to 4:00 pm
  • Language:English, Mandarin Chinese

Contact Us

  • Address 4725 N. Federal Highway Cancer Center
    Fort Lauderdale, FL 33308
  • Phone (954) 267-7700
  • Fax (954) 267-7799

Our Patient Satisfaction Rating is an average of all responses to care provider related questions
from our nationally recognized Press Ganey Patient Satisfaction Survey.

Focus Areas

Hematology and Oncology

Languages Spoken

English, Mandarin Chinese

Residency/Fellowship

Oncology/Hematology Clinical Fellow, National Institute of Health/ National Cancer Institute/National Heart Lung and Blood Institute, Bethesda, MD, 2006-2009 Internal Medicine Internship and Residency, Cincinnati Jewish Hospital, Cincinnati, OH, 2001-2004

Higher Education

Nanjing Medical College of TCM, Nanjing, China, M.D., 1992

Location

4725 N. Federal Highway Cancer Center
Fort Lauderdale, FL 33308

Notes

Office Hours
Monday-Friday  9:00 am to 12:00 pm, 1:00 pm to 4:00 pm

Click here to view Dr. Drew's Webisode
Click here for a PDF of Dr. Drew's May 2016 Lung Cancer presentation
C
likc here to view Dr. Drew's Anterior Approach to Bone Marrow Biopsy for Clinicians  

Focus Areas
General adult oncology with special emphasis on benign/malignant hematology and lung cancer

Certifications
American Board of Internal Medicine
American Board of Internal Medicine - Hematology and Medical Oncology

Residency / Fellowship
Oncology/Hematology Clinical Fellow, National Institute of Health/ National Cancer Institute/National Heart Lung and Blood Institute, Bethesda, MD, 2006-2009
Internal Medicine Internship and Residency, Cincinnati Jewish Hospital, Cincinnati, OH, 2001-2004

Higher Education
Nanjing Medical College of TCM, Nanjing, China, M.D., 1992

Research/Publications/Presentations
GYN 19 - A Randomized Phase Ii Study of Paclitaxel/Carboplatin with or Without Sorafenib in the First-Line Treatment of Patients with Stage Ill/Iv Epithelial Ovarian Cancer,   sub-PI, 2010,  Holy Cross Hospital

CA184-035 - A Multicenter Treatment Protocol for Expanded Access Use ofIpilimumab (BMS-734016) Monotherapy in Subjects with Unresectable Stage III orStage IV Melanoma   sub-PI, 2010,  Holy Cross Hospital

LYM66 (PI) - Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma    PI, 2011,  Holy Cross Hospital

VALOR study (PI) – A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients with  First Relapsed or Refractory Acute Myeloid Leukemia,  PI,  Holy Cross Hospital

 

149 Patient Satisfaction Ratings

Our Patient Satisfaction Rating is an average of all responses to care provider related questions
from our nationally recognized Press Ganey Patient Satisfaction Survey.

Overall Rating

Star with circle Star with circle Star with circle Star with circle Star with circle 4.7/5.0

Rating Breakdown

4.7 Know important info medical history
Star rating Star rating Star rating Star rating Star rating
4.8 Show respect for what you say
Star rating Star rating Star rating Star rating Star rating
4.8 Spend enough time with you
Star rating Star rating Star rating Star rating Star rating
4.7 Rate provider 0-10
Star rating Star rating Star rating Star rating Star rating
4.7 Recommend this provider office
Star rating Star rating Star rating Star rating Star rating
4.7 Provider expl in way you understand
Star rating Star rating Star rating Star rating Star rating
4.7 Provider listen carefully to you
Star rating Star rating Star rating Star rating Star rating
4.7 Give easy to understand instruction
Star rating Star rating Star rating Star rating Star rating

40 Patient Comments

4.6
Comment Star rating Comment Star rating Comment Star rating Comment Star rating Comment Star rating
March 21, 2019

Great physician.

5.0
Comment Star rating Comment Star rating Comment Star rating Comment Star rating Comment Star rating
March 19, 2019

excellent.

5.0
Comment Star rating Comment Star rating Comment Star rating Comment Star rating Comment Star rating
March 19, 2019

Extremely good!

4.9
Comment Star rating Comment Star rating Comment Star rating Comment Star rating Comment Star rating
March 03, 2019

Excellent, My experience is that Holy Cross is an excellent guardian of my health.